経腸栄養剤の世界市場：製品別、フロータイプ別、ステージ別、適応症別、最終用途別、販売チャネル別、地域別

経腸栄養剤の世界市場は、2025年には69億4,000万米ドルと推定され、2032年には131億米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は9.5%で成長すると予測されています。

経腸栄養剤は、十分な経口摂取ができない人の胃、十二指腸、空腸に直接投与する栄養補助食品です。経腸栄養剤にはさまざまな種類があります。タンパク質を主栄養素とする経腸栄養剤は、炭水化物または脂肪の摂取は最低限で栄養補給が必要な人に使用されます。標準的な経腸栄養剤には、炭水化物、タンパク質、および脂肪がバランスよく配合されています。これらの処方は、1日に必要な栄養のほとんどを満たし、長期的な使用に適しています。疾患特異的処方は、糖尿病、腎不全、肝疾患などの特定の健康状態に合わせて調整されています。食物繊維含有製剤は、正常な腸の働きを促進するために、水溶性食物繊維と不溶性食物繊維が配合されています。

それぞれのタイプに長所と短所があります。タンパク質ベースのフォーミュラは、過剰なカロリーを摂取せずにタンパク質の必要量を満たすのに役立つが、バランスのとれた栄養が不足しています。標準的な処方は、バランスの取れた栄養を提供するが、特別な食事のニーズを満たさない場合があります。疾患特異的フォーミュラは、特定の疾患特有の栄養要求に対応するが、コストが高くなります。食物繊維を含むフォーミュラは、規則正しい排便を助けるが、粘度が高く、カロリーが高いです。個人の健康状態、栄養要求量、および耐容性に基づいて、適切な処方を選択する必要があります。経腸栄養は、経口摂取で栄養を得ることができない患者に十分な栄養を確保します。

市場力学：

世界の経腸栄養剤市場は、高齢者人口の増加、慢性疾患の罹患率の増加、早産数の増加、成人の嚥下障害の急増によって牽引されています。国連の予測によると、60歳以上の高齢者人口は2050年までにほぼ倍増し、若者人口を上回る規模になります。高齢者は、認知症や手術後の合併症など、経腸栄養補助を必要とする状態に陥りやすいです。さらに、経腸栄養補助を必要とするがん、神経疾患、胃腸疾患などの慢性疾患は国際的に増加傾向にあります。これは市場の成長にプラスの影響を与えています。しかし、代替供給方法の利用可能性、チューブに伴う感染リスク、特殊処方の高コストが市場成長を抑制しています。オーガニック、非遺伝子組み換え（non-GMO）、アレルゲンフリー処方の開発は、市場関係者に有利な機会を提供しています。

本調査の主な特徴

• この調査レポートは、世界の経腸栄養剤市場を詳細に分析し、2024年を基準年とした予測期間2025-2032年の市場規模および年間平均成長率（CAGR%）を掲載しています。
• さまざまなセグメントにわたる潜在的な収益成長機会を解明し、この市場の魅力的な投資提案マトリクスを説明します。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競合戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の経腸栄養剤市場の主要企業をプロファイルしています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。
• 経腸栄養剤の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の経腸栄養剤市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• サービス提供ポートフォリオ
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• パイプライン分析

第4章 世界の経腸栄養剤市場- コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界の経腸栄養剤市場、製品別、2020年～2032年

• 標準式
• 疾患特有の処方
• 元素式
• 特殊な処方

第6章 世界の経腸栄養剤市場、フロータイプ別、2020年～2032年

• 間欠給餌フロー
• 常用供給フロー

第7章 世界の経腸栄養剤市場、ステージ別、2020年～2032年

• 大人
• 小児

第8章 世界の経腸栄養剤市場、適応症別、2020年～2032年

• アルツハイマー病
• 栄養不足
• がんケア
• 糖尿病
• 慢性腎臓病
• 希少疾患
• 嚥下障害
• 疼痛管理
• その他（吸収不良・消化器障害・下痢など）

第9章 世界の経腸栄養剤市場、最終用途別、2020-2032年

• 病院
• 心臓病学
• 神経学
• 集中治療室（ICU）
• 腫瘍学
• 在宅ケア
• その他

第10章 世界の経腸栄養剤市場、販売チャネル別、2020年～2032年

• オンライン販売
• 小売売上高
• 機関投資家向け販売

第11章 世界の経腸栄養剤市場、地域別、2020年～2032年

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第12章 競合情勢

• Nestle
• VICTUS
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co., Ltd.
• Mead Johnson & Company, LLC
• Abbott
• Danone S.A
• Fresenius Kabi AG

第13章 セクション

• 調査手法
• 出版社について

Global Enteral Feeding Formulas Market is estimated to be valued at USD 6.94 Bn in 2025 and is expected to reach USD 13.1 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

Market Dynamics:

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study:

• This report provides an in-depth analysis of the global enteral feeding formulas market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global enteral feeding formulas market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market

Global Enteral Feeding Formulas Market Detailed Segmentation:

• By Product
  • Standard Formula
  • Disease-specific Formulas
  • Elemental Formulas
  • Specialized Formulas
• By Flow Type
  • Intermittent Feeding Flow
  • Continuous Feeding Flow
• By Stage
  • Adults
  • Pediatrics
• By Indication
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Others (Malabsorption/GI Disorder/Diarrhea, etc.)
• By End Use
  • Hospitals
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
  • Others
  • Home Care
• By Sales Channel
  • Online Sales
  • Retail Sales
  • Institutional Sales
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Nestle
  • VICTUS
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co., Ltd.
  • Mead Johnson & Company, LLC
  • Abbott
  • Danone S.A
  • Fresenius Kabi AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Enteral Feeding Formulas Market, By Product
  • Global Enteral Feeding Formulas Market, By Flow Type
  • Global Enteral Feeding Formulas Market, By Stage
  • Global Enteral Feeding Formulas Market, By Indication
  • Global Enteral Feeding Formulas Market, By End User
  • Global Enteral Feeding Formulas Market, By Sales Channel
  • Global Enteral Feeding Formulas Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising incidence of chronic diseases
  • Changes in healthcare landscape and reimbursement policies
  • Increasing preference for homecare services
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Enteral Feeding Formulas Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Enteral Feeding Formulas Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Standard Formula
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Disease-specific Formulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Elemental Formulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Specialized Formulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Enteral Feeding Formulas Market, By Flow Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Intermittent Feeding Flow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Continuous Feeding Flow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Enteral Feeding Formulas Market, By Stage, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pediatrics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Enteral Feeding Formulas Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Alzheimer's
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nutrition Deficiency
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cancer Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Chronic Kidney Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Orphan Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Dysphagia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others (Malabsorption/GI Disorder/Diarrhea, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Enteral Feeding Formulas Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cardiology
• Neurology
• Critical Care (ICU)
• Oncology
• Others
• Home Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Global Enteral Feeding Formulas Market, By Sales Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Retail Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Institutional Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

11. Global Enteral Feeding Formulas Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

12. Competitive Landscape

• Nestle
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
• Strategies
• VICTUS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Primus Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Meiji Holdings. Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mead Johnson & Company, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Danone S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fresenius Kabi AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

13. Section

• Research Methodology
• About us